Approaches to neuroprotective strategies in multiple sclerosis

Area of Science:

• Neurology
• Neuroimmunology
• Neurodegeneration

Background:

• Multiple sclerosis (MS) is a leading cause of nontraumatic disability in young adults.
• Understanding the pathophysiology of MS is crucial for developing effective treatments.

Purpose of the Study:

• To review recent advances in understanding the natural history and mechanisms of MS.
• To highlight the evolution of MS from an inflammatory to a neurodegenerative phase.
• To discuss emerging therapeutic targets based on new insights.

Main Methods:

• Review of the natural history of multiple sclerosis.
• Discussion of methods for measuring disease activity and burden.
• Analysis of cellular and molecular mechanisms underlying MS-related damage.

Main Results:

• Recent advances show MS progresses from an inflammatory to a neurodegenerative phase.
• Different therapeutic strategies are required for each phase of MS.
• New therapeutic targets are emerging from a deeper understanding of MS pathology.

Conclusions:

• Multiple sclerosis involves a long-term accumulation of deficit, with neuroinflammation transitioning to neurodegeneration.
• Effective treatment requires distinct strategies: immune modulation for inflammation and neuroprotection for degeneration.
• Neuroprotective strategies are currently under development and represent a key area for future research.